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 Figure 2: Example of a Timeline cluster diagram for a cluster trial with a risk of recruitment bias: a cluster trial 
evaluating a hip protector to reduce hip fractures in older adults13 
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 Cluster identification 
Community-based healthcare centers in the southern and central parts of Finland are approached. In 
each center that agrees to participate in the trial, the local research coordinator identifies treatment 
units that care for older adults at high risk of hip fracture (geriatric long-stay facilities or outpatient 
care units for supported living at home). 
 Cluster recruitment 
Research coordinator takes consent from treatment unit. 
 
 Participant identification 
All eligible subjects in the treatment unit are identified by the research coordinator with the help of 
the other caregivers. 
 Participant baseline assessment 
Baseline data for eligible subjects are collected by the research coordinator with the help of the other 
caregivers from the treatment unit. 
 Randomisation  
Randomisation with a 1:2 ratio (allocating more clusters in the control group) is performed at 
treatment unit level by an independent physician, at the President Urho Kaleva Kekkonen Institute for 
Health Promotion Research, by using sealed envelopes.  
All clusters (treatment units) from a given healthcare center are randomised at once as soon as 
participant identification is completed within this center. 
 Participant recruitment 
Participants (or their family members) receive information and provide written consent. 
During the trial, participants who have consented but drop out because of death, new inability to 
walk, hip fracture or withdrawal of consent, are replaced, whenever possible, by new eligible subjects 
from a waiting list.  
No blinding for recruiters and participants. 
 Intervention delivery 
Participants wear of a hip protector whenever they are on their feet. 
No blinding for care providers and participants. 
 Usual care 
None of the participants use a hip protector. 
No blinding for care providers and participants. 
 Participant outcome assessment 
Fracture of the hip or the proximal femur prospectively recorded during the study and confirmed by 
radiographs.*  
*We used the report of the trial to apply the Timeline cluster tool post hoc for illustrative purpose. We assumed that those who 
read the radiographs were blinded although this is not clearly specified in the report. 
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